A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication.

PubWeight™: 2.36‹?› | Rank: Top 2%

🔗 View Article (PMC 321395)

Published in J Virol on February 01, 2004

Authors

Shihyun You1, Decherd D Stump, Andrea D Branch, Charles M Rice

Author Affiliations

1: Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York 10021, USA.

Articles citing this

Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. J Virol (2005) 3.21

Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J Virol (2007) 3.18

Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol (2006) 1.90

A comparative method for finding and folding RNA secondary structures within protein-coding regions. Nucleic Acids Res (2004) 1.89

Cis-acting RNA elements in human and animal plus-strand RNA viruses. Biochim Biophys Acta (2009) 1.67

Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci U S A (2007) 1.64

The hepatitis C virus RNA 3'-untranslated region strongly enhances translation directed by the internal ribosome entry site. J Virol (2006) 1.63

Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic Acids Res (2008) 1.63

Studying hepatitis C virus: making the best of a bad virus. J Virol (2007) 1.62

3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol (2007) 1.62

Unifying evolutionary and thermodynamic information for RNA folding of multiple alignments. Nucleic Acids Res (2008) 1.47

Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras. J Virol (2007) 1.44

Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay. Antimicrob Agents Chemother (2005) 1.38

Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J Virol (2004) 1.36

RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA (2010) 1.35

A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome. RNA (2009) 1.34

The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology (2008) 1.31

Statistical evidence for conserved, local secondary structure in the coding regions of eukaryotic mRNAs and pre-mRNAs. Nucleic Acids Res (2005) 1.30

High-resolution functional profiling of hepatitis C virus genome. PLoS Pathog (2008) 1.30

cis-acting RNA signals in the NS5B C-terminal coding sequence of the hepatitis C virus genome. J Virol (2004) 1.26

Molecular virology of hepatitis C virus (HCV): 2006 update. Int J Med Sci (2006) 1.24

A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B. J Virol (2008) 1.22

Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells. J Virol (2006) 1.21

Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L. Virus Res (2007) 1.18

Structural and functional analysis of hepatitis C virus strain JFH1 polymerase. J Virol (2009) 1.17

The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells. J Virol (2007) 1.16

Efficient algorithms for probing the RNA mutation landscape. PLoS Comput Biol (2008) 1.15

RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells. PLoS Pathog (2010) 1.10

Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging. J Virol (2006) 1.10

A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes. J Virol (2011) 1.07

RNAsnp: efficient detection of local RNA secondary structure changes induced by SNPs. Hum Mutat (2013) 1.03

Evidence of structural genomic region recombination in Hepatitis C virus. Virol J (2006) 1.01

RNAmute: RNA secondary structure mutation analysis tool. BMC Bioinformatics (2006) 1.00

The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific Manner. Open Biochem J (2009) 1.00

The RNAsnp web server: predicting SNP effects on local RNA secondary structure. Nucleic Acids Res (2013) 1.00

3' cis-acting elements that contribute to the competence and efficiency of Japanese encephalitis virus genome replication: functional importance of sequence duplications, deletions, and substitutions. J Virol (2009) 0.97

Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy. Virol J (2006) 0.97

A twist in the tail: SHAPE mapping of long-range interactions and structural rearrangements of RNA elements involved in HCV replication. Nucleic Acids Res (2012) 0.96

Functionally conserved architecture of hepatitis C virus RNA genomes. Proc Natl Acad Sci U S A (2015) 0.96

A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A. PLoS One (2011) 0.94

Identification of a conserved RNA replication element (cre) within the 3Dpol-coding sequence of hepatoviruses. J Virol (2008) 0.93

Hepatitis C virus RNA: molecular switches mediated by long-range RNA-RNA interactions? Nucleic Acids Res (2012) 0.92

Systematic analysis of enhancer and critical cis-acting RNA elements in the protein-encoding region of the hepatitis C virus genome. J Virol (2013) 0.91

Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations. Hepatology (2011) 0.91

End-to-end crosstalk within the hepatitis C virus genome mediates the conformational switch of the 3'X-tail region. Nucleic Acids Res (2013) 0.89

Evidence of pervasive biologically functional secondary structures within the genomes of eukaryotic single-stranded DNA viruses. J Virol (2013) 0.88

The Coding Region of the HCV Genome Contains a Network of Regulatory RNA Structures. Mol Cell (2016) 0.87

The RNAmute web server for the mutational analysis of RNA secondary structures. Nucleic Acids Res (2011) 0.86

EWSR1 binds the hepatitis C virus cis-acting replication element and is required for efficient viral replication. J Virol (2013) 0.86

The folding of the hepatitis C virus internal ribosome entry site depends on the 3'-end of the viral genome. Nucleic Acids Res (2012) 0.86

An efficient method for the prediction of deleterious multiple-point mutations in the secondary structure of RNAs using suboptimal folding solutions. BMC Bioinformatics (2008) 0.85

Inhibition of HCV translation by disrupting the structure and interactions of the viral CRE and 3' X-tail. Nucleic Acids Res (2015) 0.83

Direct evidence for RNA-RNA interactions at the 3' end of the Hepatitis C virus genome using surface plasmon resonance. RNA (2013) 0.83

Efficient procedures for the numerical simulation of mid-size RNA kinetics. Algorithms Mol Biol (2012) 0.83

Conformational organization of the 3' untranslated region in the tomato bushy stunt virus genome. RNA (2006) 0.83

Bluetongue virus VP1 polymerase activity in vitro: template dependency, dinucleotide priming and cap dependency. PLoS One (2011) 0.83

Identification of novel RNA secondary structures within the hepatitis C virus genome reveals a cooperative involvement in genome packaging. Sci Rep (2016) 0.82

corRna: a web server for predicting multiple-point deleterious mutations in structural RNAs. Nucleic Acids Res (2011) 0.81

The C-terminal hydrophobic domain of hepatitis C virus RNA polymerase NS5B can be replaced with a heterologous domain of poliovirus protein 3A. J Virol (2006) 0.81

Hepatitis C virus RNA replication requires a conserved structural motif within the transmembrane domain of the NS5B RNA-dependent RNA polymerase. J Virol (2010) 0.81

The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA. Nat Rev Microbiol (2015) 0.81

Identification of a structural element of the hepatitis C virus minus strand RNA involved in the initiation of RNA synthesis. Nucleic Acids Res (2010) 0.80

Hepatitis C virus RNA replication depends on specific cis- and trans-acting activities of viral nonstructural proteins. PLoS Pathog (2015) 0.80

Altering SARS coronavirus frameshift efficiency affects genomic and subgenomic RNA production. Viruses (2013) 0.80

The cis-acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation. Sci Rep (2016) 0.80

Widespread signatures of local mRNA folding structure selection in four Dengue virus serotypes. BMC Genomics (2015) 0.79

Hydrophobic and charged residues in the C-terminal arm of hepatitis C virus RNA-dependent RNA polymerase regulate initiation and elongation. J Virol (2014) 0.78

Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element. Pharmaceuticals (Basel) (2011) 0.78

Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development. Virus Evol (2016) 0.78

Internal RNA Replication Elements are Prevalent in Tombusviridae. Front Microbiol (2012) 0.78

Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol (2012) 0.77

Evolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American region. Virol J (2007) 0.77

Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics. World J Gastroenterol (2010) 0.77

Flexible and rapid construction of viral chimeras applied to hepatitis C virus. J Gen Virol (2016) 0.76

Phylogenetic prediction of cis-acting elements: a cre-like sequence in Norovirus genome? BMC Res Notes (2009) 0.76

Secondary Structural Elements of the HCV X-region Involved in Viral Replication. J Clin Transl Hepatol (2015) 0.75

The chaperone-like activity of the hepatitis C virus IRES and CRE elements regulates genome dimerization. Sci Rep (2017) 0.75

Exploiting cis-acting replication elements to direct hepatitis C virus-dependent transgene expression. J Virol (2005) 0.75

Affinity Purification of the Hepatitis C Virus Replicase Identifies Valosin-Containing Protein, a Member of the ATPases Associated with Diverse Cellular Activities Family, as an Active Virus Replication Modulator. J Virol (2016) 0.75

Polyprotein-Driven Formation of Two Interdependent Sets of Complexes Supporting Hepatitis C Virus Genome Replication. J Virol (2015) 0.75

Nuclear Magnetic Resonance Study of RNA Structures at the 3'-End of the Hepatitis C Virus Genome. Biochemistry (2017) 0.75

Articles cited by this

Nucleotide sequence of bacteriophage phi X174 DNA. Nature (1977) 95.69

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science (1999) 24.31

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (1979) 15.42

Efficient initiation of HCV RNA replication in cell culture. Science (2000) 15.12

Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol (2002) 11.99

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science (1985) 8.54

Replication of hepatitis C virus. J Gen Virol (2000) 6.08

Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science (1985) 5.90

A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J (1990) 5.74

The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol (1990) 5.19

Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol (1996) 4.59

Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J (1995) 4.44

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol (1999) 4.37

Poliovirus RNA replication requires genome circularization through a protein-protein bridge. Mol Cell (2001) 3.57

Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA (2001) 3.55

Automatic detection of conserved RNA structure elements in complete RNA virus genomes. Nucleic Acids Res (1998) 3.18

Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA (1996) 3.14

Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology (1996) 3.14

Identification of a cis-acting replication element within the poliovirus coding region. J Virol (2000) 3.03

5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis. EMBO J (2001) 2.67

Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication. J Virol (2002) 2.62

The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication. RNA (1998) 2.61

In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. Proc Natl Acad Sci U S A (1999) 2.56

Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem (2001) 2.45

3' nontranslated RNA signals required for replication of hepatitis C virus RNA. J Virol (2003) 2.41

A brome mosaic virus intergenic RNA3 replication signal functions with viral replication protein 1a to dramatically stabilize RNA in vivo. J Virol (1999) 2.31

Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA. J Virol (1997) 2.30

A novel in vitro replication system for Dengue virus. Initiation of RNA synthesis at the 3'-end of exogenous viral RNA templates requires 5'- and 3'-terminal complementary sequence motifs of the viral RNA. J Biol Chem (1999) 2.28

A coding RNA sequence acts as a replication signal in cardioviruses. Proc Natl Acad Sci U S A (1999) 2.22

Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA (2002) 2.20

Phylogenetic comparative analysis of RNA secondary structure. Methods Enzymol (1989) 2.18

Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA (2001) 2.17

Crystal structure of an RNA tertiary domain essential to HCV IRES-mediated translation initiation. Nat Struct Biol (2002) 2.14

The encapsidation signal on the hepatitis B virus RNA pregenome forms a stem-loop structure that is critical for its function. Nucleic Acids Res (1993) 2.04

Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J (2001) 2.03

Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus. J Virol (1998) 2.00

Base-pairing between untranslated regions facilitates translation of uncapped, nonpolyadenylated viral RNA. Mol Cell (2001) 1.97

cis- and trans-acting elements in flavivirus RNA replication. J Virol (2000) 1.91

Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J Virol (2002) 1.88

Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88

Internal ribosome entry site-mediated translation in hepatitis C virus replication. Curr Top Microbiol Immunol (2000) 1.78

The influence of downstream protein-coding sequence on internal ribosome entry on hepatitis C virus and other flavivirus RNAs. RNA (2001) 1.77

Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol (1996) 1.72

Silent mutations affect in vivo protein folding in Escherichia coli. Biochem Biophys Res Commun (2002) 1.69

Long-distance base pairing in flock house virus RNA1 regulates subgenomic RNA3 synthesis and RNA2 replication. J Virol (2002) 1.61

Recognition of bacteriophage Qbeta plus strand RNA as a template by Qbeta replicase: role of RNA interactions mediated by ribosomal proteins S1 and host factor. J Mol Biol (1997) 1.55

Protein secondary structural types are differentially coded on messenger RNA. Protein Sci (1996) 1.47

Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol (1996) 1.46

Poliovirus cre(2C)-dependent synthesis of VPgpUpU is required for positive- but not negative-strand RNA synthesis. J Virol (2003) 1.43

Functional dissection of a poliovirus cis-acting replication element [PV-cre(2C)]: analysis of single- and dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. J Virol (2003) 1.37

A long-range interaction in Qbeta RNA that bridges the thousand nucleotides between the M-site and the 3' end is required for replication. RNA (1998) 1.31

Lead(II) as a probe for investigating RNA structure in vivo. RNA (2002) 1.31

Hepatitis C virus 3'X region interacts with human ribosomal proteins. J Virol (2001) 1.29

Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3' end of the viral RNA. J Virol (1999) 1.28

Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem (2002) 1.25

The Brome mosaic virus subgenomic promoter hairpin is structurally similar to the iron-responsive element and functionally equivalent to the minus-strand core promoter stem-loop C. RNA (2002) 1.24

Interaction of poly(rC)-binding protein 2 with the 5'-terminal stem loop of the hepatitis C-virus genome. Virus Res (2001) 1.22

Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem (2003) 1.22

Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol (2000) 1.22

Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human La autoantigen. J Biol Chem (2003) 1.20

Structure and function analysis of the poliovirus cis-acting replication element (CRE). RNA (2003) 1.17

The brome mosaic virus RNA3 intergenic replication enhancer folds to mimic a tRNA TpsiC-stem loop and is modified in vivo. RNA (2001) 1.16

Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA (2002) 1.13

Binding of the La autoantigen to the hepatitis C virus 3' untranslated region protects the RNA from rapid degradation in vitro. J Gen Virol (2001) 1.13

Triple decoding of hepatitis C virus RNA by programmed translational frameshifting. Mol Cell Biol (2003) 1.07

Kissing interaction between 3' noncoding and coding sequences is essential for porcine arterivirus RNA replication. J Virol (2002) 1.07

A branched stem-loop structure in the M-site of bacteriophage Qbeta RNA is important for template recognition by Qbeta replicase holoenzyme. J Mol Biol (1998) 1.04

Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. J Gen Virol (1999) 1.03

Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: purification and enzymatic analysis of the RNA-dependent RNA polymerase 3D(pol). J Virol (2001) 1.00

Distinct requirements for primary sequence in the 5'- and 3'-part of a bulge in the hepatitis B virus RNA encapsidation signal revealed by a combined in vivo selection/in vitro amplification system. Nucleic Acids Res (1995) 0.98

Clinical relevance of hepatitis C virus genotypes. Gut (1997) 0.95

Pseudoknots in prion protein mRNAs confirmed by comparative sequence analysis and pattern searching. Nucleic Acids Res (2001) 0.92

Articles by these authors

Complete replication of hepatitis C virus in cell culture. Science (2005) 18.59

Identification of microRNAs of the herpesvirus family. Nat Methods (2005) 12.98

A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol (2002) 11.99

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature (2007) 9.52

Suppression of inflammation by a synthetic histone mimic. Nature (2010) 8.80

Replication of hepatitis C virus. Nat Rev Microbiol (2007) 8.31

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A (2003) 8.21

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature (2009) 8.05

Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A (2007) 6.79

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology (2006) 6.16

Unravelling hepatitis C virus replication from genome to function. Nature (2005) 5.25

HCV persistence and immune evasion in the absence of memory T cell help. Science (2003) 5.23

Molecular biology of flaviviruses. Adv Virus Res (2003) 4.39

Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol (2007) 4.28

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (2014) 4.15

Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol (2003) 3.84

Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature (2005) 3.83

Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol (2006) 3.71

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A (2006) 3.69

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol (2004) 3.53

Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 3.47

Rare birds in North America: acute hepatitis C cohorts. Gastroenterology (2008) 3.45

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology (2006) 3.44

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol (2010) 3.44

Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol (2011) 3.44

Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol (2004) 3.39

Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature (2013) 3.39

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci U S A (2002) 3.21

Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol (2003) 3.19

The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem (2004) 3.15

A genetically humanized mouse model for hepatitis C virus infection. Nature (2011) 3.15

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol (2003) 3.10

Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol (2002) 3.07

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology (2008) 2.91

Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A (2004) 2.77

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol (2009) 2.68

Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol (2007) 2.65

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med (2013) 2.63

Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature (2006) 2.58

Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe (2009) 2.58

Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J Virol (2002) 2.55

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood (2005) 2.50

Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood (2011) 2.49

Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog (2010) 2.48

Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein. J Virol (2007) 2.45

Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44

euHCVdb: the European hepatitis C virus database. Nucleic Acids Res (2006) 2.41

MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature (2013) 2.40

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology (2004) 2.37

Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol (2002) 2.31

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med (2009) 2.26

A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol (2003) 2.25

Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20

Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol (2003) 2.20

Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A (2011) 2.14

Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology (2011) 2.13

Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus. Hepatology (2015) 2.11

Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08

Diverse CD81 proteins support hepatitis C virus infection. J Virol (2006) 2.07

A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology (2011) 2.06

Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science (2012) 2.06

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci U S A (2012) 2.05

Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology (2006) 2.04

Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc Natl Acad Sci U S A (2004) 2.04

Tracking and elucidating alphavirus-host protein interactions. J Biol Chem (2006) 2.01

An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication. J Virol (2004) 1.99

Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism. Proc Natl Acad Sci U S A (2009) 1.94

Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol (2003) 1.93

Hepatitis C virus entry. J Biol Chem (2007) 1.91

Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol (2002) 1.87

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J Gen Virol (2009) 1.87

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci U S A (2013) 1.85

PKR-dependent and -independent mechanisms are involved in translational shutoff during Sindbis virus infection. J Virol (2004) 1.81

Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol (2012) 1.80

Uncleaved NS2-3 is required for production of infectious bovine viral diarrhea virus. J Virol (2004) 1.79

Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis (2008) 1.78

Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology (2006) 1.75

High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol (2007) 1.73

Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog (2009) 1.73

Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. J Virol (2007) 1.73

Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood (2007) 1.72

Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med (2005) 1.71

Superinfection exclusion in cells infected with hepatitis C virus. J Virol (2007) 1.71

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut (2014) 1.70

The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol (2013) 1.69

A dynamic view of hepatitis C virus replication complexes. J Virol (2008) 1.66

Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J Clin Invest (2006) 1.66

Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci U S A (2007) 1.64

Studying hepatitis C virus: making the best of a bad virus. J Virol (2007) 1.62

3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol (2007) 1.62

Identification of rodent homologs of hepatitis C virus and pegiviruses. MBio (2013) 1.61

Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol (2002) 1.61

Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol (2008) 1.60

Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A (2012) 1.48

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. Gastroenterology (2005) 1.47

Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. J Exp Med (2005) 1.46

Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44

Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43